KalVista Pharmaceuticals, Inc. (KALV)
16.86
+0.70
(+4.33%)
USD |
NASDAQ |
Dec 10, 16:00
16.70
-0.16
(-0.95%)
After-Hours: 07:12
KalVista Pharmaceuticals EPS Diluted (Quarterly): -0.9183 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 0.0587 |
| Revolution Medicines, Inc. | -1.613 |
| Silvergate Capital Corp. | -- |
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -49.48M |
| Revenue (Quarterly) | 13.69M |
| Total Expenses (Quarterly) | 63.17M |
| Enterprise Value | 825.63M |
| Gross Profit Margin (Quarterly) | 91.00% |
| Profit Margin (Quarterly) | -361.4% |
| Earnings Yield | -23.80% |
| Normalized Earnings Yield | -23.67 |